NCAM1 and Hepatic fibrosis: The results of this study suggest that AUD patients with advanced liver fibrosis have more cytotoxic CD56+CD16+ NK cells, fewer cytokine-secreting CD56+CD16− NK cells and an increased lymphocyte activation, defined by HLA-DR expression, than patients without advanced liver fibrosis.